Physician

Ganga Ranasuriya

According to 2025 Medicare claims, Ganga Ranasuriya (NPI: 1013350362) practices pulmonary disease in the Williamsport, PA market, with the plurality of this provider's patient population coming from Lycoming, PA. This provider's primary affiliated billing organization is SUSQUEHANNA PHYSICIAN SERVICES (NPI: 1083677868; TIN: 232449454) and primary practice location at 17701-3100. Ranasuriya is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Ranasuriya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 592 traditional Medicare patients, billed 5,208 HCPCS/CPT codes, and received $227,409 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,303 prescription claims across 401 beneficiaries totaling $3,336,392 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 1,526 claims. Open Payments data shows 15 records totaling $6,680. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $17,447 to $227,409. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,621 to $3,336,392. For DME billing, reported payments moved sharply higher in recent years, from $9,319 to $225,258.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	99	356	$17,447
2016	503	2,509	$126,272
2017	441	1,856	$96,263
2018	650	1,783	$90,481
2019	609	1,899	$148,474
2020	482	1,529	$105,516
2021	585	2,482	$140,431
2022	628	2,956	$172,752
2023	679	4,678	$228,899
2024	592	5,208	$227,409

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	35	96	$15,621
2016	123	511	$219,234
2017	132	746	$340,717
2018	206	1,101	$668,970
2019	236	1,534	$1,069,232
2020	246	1,876	$1,410,907
2021	277	2,320	$2,226,557
2022	360	2,839	$2,840,410
2023	400	3,305	$3,106,618
2024	401	3,303	$3,336,392

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	34	260	$16,775
2017	59	478	$17,902
2018	91	721	$35,066
2019	143	1,183	$104,208
2020	132	1,255	$138,805
2021	160	1,167	$153,060
2022	144	1,144	$180,015
2023	199	1,422	$208,952
2024	248	1,526	$240,898

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	229	285	$87
94726	Test to determine lung volumes using sensors	115	115	$9
94727	Test to determine lung volumes using gas dilution or washout	135	135	$8
94729	Test to examine how well the lungs exchange gases	280	282	$6
94010	Test to measure expiratory airflow and volume	310	318	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	101	3,030	$1,338,605
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	693	24,540	$504,117
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	343	11,910	$178,576
Prolastin C	Alpha-1-Proteinase Inhibitor	15	399	$165,128
Breo Ellipta	Fluticasone/Vilanterol	226	8,820	$112,631

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	17	111	$103,157
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	57	$57,631
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	49	396	$37,797
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	14	$10,673
E1392	Portable oxygen concentrator, rental	Y	24	153	$5,667

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$6,680	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ganga Ranasuriya?

Tedicare shows public-source Medicare data for Ganga Ranasuriya (NPI 1013350362), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ganga Ranasuriya have ACO affiliation data?

Ganga Ranasuriya is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Ganga Ranasuriya?

Ganga Ranasuriya is linked to SUSQUEHANNA PHYSICIAN SERVICES (billing NPI 1083677868) in the available physician profile data.

Does Ganga Ranasuriya have Open Payments data?

Ganga Ranasuriya has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.